Delpacibart zotadirsen
Based on 1 Customer Validation
Delpacibart zotadirsen (Del-zota), an antibody oligonucleotide conjugate (AOC), consists of a monoclonal antibody (Delpacibart) (HY-P990051) that binds to the transferrin receptor 1 (TfR1) conjugated to a phosphorodiamidate morpholino conjugate (PMO), Delpacibart zotadirsen is designed to deliver phosphorodiamidate morpholino oligomers (PMOs) to skeletal muscle and heart tissue to specifically skip exon 44 of the dystrophin gene and enable production of near-full length dystrophin. Delpacibart zotadirsen is used for the study of myotonic dystrophy type 1 (DM1).
For research use only. We do not sell to patients.
- Purity: 92.88%
- CAS No.: 2929240-20-8
-
Storage:
-80°C, protect from light
All Antibody-Oligonucleotide Conjugates (AOCs) Isoforms
More
Biological Activity
Delpacibart zotadirsen is primarily used in the study of Duchenne muscular dystrophy with exon 44 skipping mutations (DMD44), and can cover both ambulatory and non-ambulatory patients aged 7-27 years[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 2929240-20-8
-
Appearance Liquid
-
Color Colorless to light yellow
-
SMILES
[Delpacibart zotadirsen]
-
Synonyms
Del-zota; AOC 1044
-
Shipping
Shipping with dry ice.
-
Storage
-80°C, protect from light
Purity & Documentation
-
Data Sheet (269 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)